Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global cholera vaccines industry is being driven by the increasing incidences of cholera worldwide. This can be attributed to the lack of proper sanitation facilities, especially in the third world economies. In addition, increased investments by the government to support the pharmaceutical industry are also projected to aid the market growth. In addition, the growing focus of international organisations such as UNICEF and WHO in strategising initiatives to combat the spread of cholera is also inviting capital expenditure in the development of effective vaccines. These factors are anticipated to propel the market growth in the forecast period.
The increased demand for efficient cholera vaccines and the heightened capital expenditure by the leading market players and the governments in research and development of vaccines are predicted to aid the market growth. For instance, in January 2020, Emergent BioSolutions Inc. (NYSE: EBS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) suggested a positive opinion for the approval of the company’s new single-dose oral cholera vaccine, Vaxchora and expected a near-term approval by the EMA, which would make Vaxchora the only single-dose oral vaccine for adults and children above 6 years, indicated for active immunisation against the disease caused by Vibrio cholerae serogroup O1. These developments are expected to positively impact the growth of the cholera vaccines industry in the forecast period.
Market Breakup by Product and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global cholera vaccines market are Sanofi-aventis Groupe, Emergent BioSolutions Inc., Valneva SE, GlaxoSmithKline plc., Intervet Inc., EuBiologics Co., Ltd., and others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.